Acadia Pharma (ACAD) – Corporate News
-
Acadia Pharma (ACAD) Appoints Elizabeth H. Z. Thompson as Head of R&D
-
Acadia Pharma (ACAD) Reports Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ACAD Stock Lookup